Classification of Hemolytic anemias I. Red cell abnormality (Intracorpuscular factors) A. Hereditary 1. Membrane defect (spherocytosis, elliptocytosis)

Slides:



Advertisements
Similar presentations
Normocytic Anemia David Lee, MD, FRCPC. Normocytic anemia a heterogenous group of anemias normocytosis implies normal DNA metabolism and hemoglobin synthesis.
Advertisements

Approach to Anemia - Summary
AN APPROACH TO THE ANEMIC PATIENT Martin H. Ellis MD Meir Hospital 2007.
Lecturer /Sulaimani College of Medicine/ Dept.of Pathology
In the name of GOD.
Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof. Dr Magda Sultan Date : 26/12/2013 Outcome : The student will know : -The types of.
Life of a Red Blood Cell Erythroid precursors undergo 4-5 divisions in marrow, extrude nucleus, become reticulocytes, enter peripheral blood, and survive.
HEMOLYTIC ANEMIA HOSEA NJOKU 1405.
Chemotherapy/ Biotherapy for Hematology Disease Processes.
Hemolytic Anemias due to Other Intracorpuscular Defects
increase red cell destruction = reduced red-cell life span
HEMOLYTIC ANEMIAS. HEMOLYTIC ANEMIA Anemia of increased destruction –Normochromic, normochromic anemia –Shortened RBC survival –Reticulocytosis - Response.
Hemolytic anemia HA = decreased levels of erythrocytes in circulating blood (anemia) because of their acclerated destruction (hemolysis) A red blood cell.
 Charachterized by:  A nemia results when the rate of destruction exceeds the capacity of the m arrow to produce RBCs(The bone marro 8 times increased.
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof. Dr Magda Sultan Outcome : The student will know : -The types of hemolytic anemias.
Week 2: Hemolytic Anemia
Introduction to Hemolytic Anemias
Splenectomy in Hematologic Disorders
Anaemia By Jeeves.
Glucose-6-phosphate Dehydration Deficiency Nada Mohamed Ahmed, MD, MT (ASCP)i.
Course title: Hematology (1) Course code: MLHE-201 Supervisor: Prof
HEREDITARY/ACQUIRED HEMOLYTIC ANEMIA
Hemolytic Anemias Defined as those anemias result from an increased in the rate of red cell destruction. The red cell destruction is usually removed extravascular.
Paroxysmal Nocturnal Hemoglobinuria (PNH)
MLAB 1415-Hematology Keri Brophy-Martinez Chapter 14: Introduction to Hemolytic Anemias.
1 Alterations of Hematologic Function in Children Chapter 28.
Haemolytic Anaemia Elliot Catchpole PCMD.
LS/MW MT 417 – Clinical Hematology II Manual/Special Tests Unit Ham’s/Sugar Water/DL Exercise Ham’s/Sugar Water/DL Questions KEY.
Hemolytic anemia Excessive destruction of red cells Acute Hemolytic anemia Chronic Hemolytic anemia Congenita l Acquired : Immune Non-immune.
MLAB 1415: Hematology Keri Brophy-Martinez
Haemolytic anaemias Dr. Suhair Abbas Ahmed.
 SCA  Hemoglobin  How it is acquired  Symptoms  What happens in SCA  Treatment.
Warm Autoimmune Hemolytic Anemia Lisa Rose-Jones, MD Monday, Aug 24th.
Anemia Kristine Krafts, M.D.. Background facts about blood Anemia: general information Anemia: specific types Anemia Outline.
Laboratory evaluation of erythrocyte RBC Haemoglobin Packed cell volume MCV MCH MCHC RDW Reticulocyte Blood film Quantitative description of erythropoiesis.
Acquired haemolytic anaemias
Auto Immune hemolytic anemia
Hemolytic anemias.
MLAB 1415: Hematology Keri Brophy-Martinez Hemolytic Anemia: Nonimmune Defects.
Acquired Haemolytic Anaemias. Haemolytic conditions are those in which: erythrocyte construction industry is healthy (usually) red cells produced have.
HEMOLYTIC ANEMIAS.
CLASSIFICATION OF ANEMIA
Red Cell Turnover and Life Span 2.5 million red cells are removed from the circulation every second. BM produces 200 billion new red cells (reticulocytes)
HEMOLYTIC DESORDERS Red Cell Turnover and Life Span 2.5 million red cells are removed from the circulation every second. BM produces 200 billion new red.
MLAB 1415: Hematology Keri Brophy-Martinez Chapter 18: Hemolytic Anemia: Nonimmune Defects.
Glucose-6-phosphate Dehydration Deficiency
Diagnostic Approaches To Anemia 1. Is the patient anemic ? 2. How severe is the anemia ? 3. What type of anemia ? 4. Why is the patient anemic? 5. What.
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives Intoduction Definition Classification Intravascular &extra vascular hemolysis Signs of hemolytic anemias.
HEMOLYTIC ANEMIA Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin.
Anemia of chronic disease is a hypoproliferative ( بالتدريج) anemia associated with chronic infectious or inflammatory processes, tissue injury, or conditions.
HAEMOLYTIC ANAEMIA HAEMOLYTIC ANAEMIA Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam.
Acquired Hemolytic Anemias
1 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE Chapter 20. Erythrocytic disorders.
SHEIKHA HEMOLYTIC ANEMIAS. SHEIKHA Abnormalities of the Environment of the Red Cells Abnormalities of the Red Cells Premature destruction of the red cells.
HEMOLYTIC ANEMIA INCREASE RED CELL DESTRUCTION =
Jaundice: Causes and Etiopathogenesis
MLAB Hematology Fall 2007 Keri Brophy-Martinez
IMMUNE HEMOLYSIS Definition : red cell life span is shortened because abnormalities in the components of the immune system are specifically directed against.
Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin
Anemia By: Dr Sunita Mittal.
HEMOLYTIC DISORDERS Red Cell Turnover and Life Span 2.5 million red cells are removed from the circulation every second. BM produces 200 billion new.
HEMOLYTIC ANEMIA Dr Ramadas Nayak
Dr. M. A Sofi MD; FRCP (London); FRCEdin; FRCSEdin
溶血性贫血 Hemolytic Anemia
MLAB 1415-Hematology Keri Brophy-Martinez
CLASSIFICATION OF ANEMIAS
Approach to Haemolysis
Presentation transcript:

Classification of Hemolytic anemias I. Red cell abnormality (Intracorpuscular factors) A. Hereditary 1. Membrane defect (spherocytosis, elliptocytosis) 2. Metabolic defect (Glucoze-6-Phosphate-Dehydrogenaze (G6PD) deficiency, Pyruvate kinase (PK) deficiency) 3. Hemoglobinopathies (unstable hemoglobins, thalassemias, sickle cell anemia ) B. Acquired 1. Membrane abnormality-paroxysmal nocturnal hemoglobinuria (PNH)

HEMOLYTIC ANEMIAS Hemolytic anemias = reduced red-cell life span

II. Extracorpuscular factors A. Immune hemolytic anemias 1. Autoimmune hemolytic anemia - caused by warm-reactive antibodies - caused by cold-reactive antibodies 2. Transfusion of incompatible blood B. Nonimmune hemolytic anemias 1. Chemicals 2. Bacterial infections, parasitic infections (malaria), venons 3. Hemolysis due to physical trauma - hemolytic - uremic syndrome (HUS) - thrombotic thrombocytopenic purpura (TTP) - prosthetic heart valves 4. Hypersplenism

Mechanisms of hemolysis: - intravascular - extravascular

Inravascular hemolysis (1): - red cells destruction occurs in vascular space - clinical states associated with Intravascular hemolysis: acute hemolytic transfusion reactions severe and extensive burns paroxysmal nocturnal hemoglobinuria severe microangiopathic hemolysis physical trauma bacterial infections and parasitic infections (sepsis)

Inravascular hemolysis (2): - laboratory signs of intravascular hemolysis: indirect hyperbilirubinemia erythroid hyperplasia hemoglobinemia methemoalbuminemia hemoglobinuria absence or reduced of free serum haptoglobin hemosiderynuria Inravascular hemolysis (2): - laboratory signs of intravascular hemolysis: indirect hyperbilirubinemia erythroid hyperplasia hemoglobinemia methemoalbuminemia hemoglobinuria absence or reduced of free serum haptoglobin hemosiderynuria

Extravascular hemolysis : - red cells destruction occurs in reticuloendothelial system - clinical states associated with extravascular hemolysis : autoimmune hemolysis delayed hemolytic transfusion reactions hemoglobinopathies hereditary spherocytosis hypersplenism hemolysis with liver disease - laboratory signs of extravascular hemolysis: indirect hyperbilirubinemia increased excretion of bilirubin by bile erythroid hyperplasia hemosiderosis Extravascular hemolysis : - red cells destruction occurs in reticuloendothelial system - clinical states associated with extravascular hemolysis : autoimmune hemolysis delayed hemolytic transfusion reactions hemoglobinopathies hereditary spherocytosis hypersplenism hemolysis with liver disease - laboratory signs of extravascular hemolysis: indirect hyperbilirubinemia increased excretion of bilirubin by bile erythroid hyperplasia hemosiderosis

Hemolytic anemia - clinical features: - pallor - jaundice - splenomegaly

Laboratory features: 1. Laboratory features - normocytic/macrocytic, hyperchromic anemia - reticulocytosis - increased serum iron - antiglobulin Coombs’ test is positive 2. Blood smear - anisopoikilocytosis, spherocytes - erythroblasts - schistocytes 3. Bone marrow smear - erythroid hyperplasia

Diagnosis of hemolytic syndrome: 1. Anemia 2. Reticulocytosis 3. Indirect hyperbilirubinemia Diagnosis of hemolytic syndrome: 1. Anemia 2. Reticulocytosis 3. Indirect hyperbilirubinemia

Autoimmune hemolytic anemia caused by warm- reactive antibodies: I. Primary II. Secondary 1. acute - viral infections - drugs (  -Methyldopa, Penicillin, Quinine, Quinidine) 2. chronic - rheumatoid arthritis, systemic lupus erythematosus - lymphoproliferative disorders (chronic lymphocytic leukemia, lymphomas, Waldenstr Ö m’s macroglobulinemia) - miscellaneous (thyroid disease, malignancy )

Autoimmune hemolytic anemia caused by cold-reactive antibodies: I. Primary cold agglutinin disease II. Secondary hemolysis: - mycoplasma infections - viral infections - lymphoproliferative disorders III. Paroxysmal cold hemoglobinuria

Autoimmune hemolytic anemia - diagnosis - positive Coombs’ test Treatment: - steroids - splenectomy - immunosupressive agents - transfusion Autoimmune hemolytic anemia - diagnosis - positive Coombs’ test Treatment: - steroids - splenectomy - immunosupressive agents - transfusion

Hereditary microspherocytosis 1. Pathophysiology - red cell membrane protein defects (spectrin deficiency) resulting cytoskeleton instability 2. Familly history 3. Clinical features - splenomegaly 4. Laboratory features - hemolytic anemia - blood smear-microspherocytes - abnormal osmotic fragility test - positive autohemolysis test - prevention of increased autohemolysis by including glucose in incubation medium 5. Treatment - splenectomy

Paroxysmal nocturnal hemoglobinuria 1. Pathogenesis - an acquired clonal disease, arising from a somatic mutation in a single abnormal stem cell - glycosyl-phosphatidyl- inositol (GPI) anchor abnormality - deficiency of the GPI anchored membrane proteins (decay-accelerating factor =CD55 and a membrane inhibitor of reactive lysis =CD59) - red cells are more sensitive to the lytic effect of complement - intravascular hemolysis 2. Symptoms - passage of dark brown urine in the morning

3. PNH –laboratory features: - pancytopenia - chronic urinary iron loss - serum iron concentration decreased - hemoglobinuria - hemosiderinuria - positive Ham’s test (acid hemolysis test) - positive sugar-water test - specific immunophenotype of erytrocytes (CD59, CD55) 4. Treatment: - washed RBC transfusion - iron therapy - allogenic bone marrow transplantation

SICKLE CELL ANEMIA Definition: chronic hemolytic anemia occuring almost exclusively in blacks and characterized by sickle-shaped red cells(RBCs) caused by homozygous inheritance of Hemoglobin S

SICKLE CELL ANEMIA-pathogenesis - In Hb S, valine is substituted for glutamic acid in the sixth amino acid of the ß chain. - Deoxy-Hb S is much less soluble than deoxy Hb A; it forms a gelatinous network of fibrous polymersthat cause RBCs to sickle at sites of low pO 2. - Hemolysis-because sickle RBCs are too fragile to withstand the mechanical trauma of circulation - Occlusion in microvascular circulation caused by distorted, inflexible RBCs adhering to vascular endothelium

SICKLE CELL ANEMIA-incidence - Homozygous - about 0,3% of blacks in the USA (have sickle cell anemia) - Hetezygotes-8-13% of blacks, (are not anemic, but the sickling trait=sicklemia can be demonstrated in vitro)

SICKLE CELL ANEMIA-clinical features IN HOMOZYGOTES 1. Clinical complications due to severe hemolytic anaemia - slowed growth and development in children - bilirubins stones - aplastic crisis - congestive heart failure from chronic anemias and cardiac overload compensation 2. Consequences of vaso-occlusion of the microcirculations (tissue ischemia and infarction) - infarction of spleen, brain, marrow, kidney, lung, aseptic necrosis, central nervous system and ophtalmic vascular lesions

SICKLE CELL ANEMIA-laboratory findinges 1. Anemia-normocytic or slightly macrocytic 2. Leukocytosis(chronic neutrophilia) 3. Thrombocytosis-usually mild<1000G/l 4. Reticulocytosis 5. Peripheral smear: sickle shaped red cells, polychromatophilia, Howell-Jolly bodies 6. Hb -electrophoresis

SICKLE CELL ANEMIA-therapy Preventive measures: prevention or remedy of: infections(penicillin prophylaxis and pneumococcal vaccination), fever, dehydratation,acidosis, hypoxemia, cold exposure Blood transfusions for very severe anemia New approaches to therapy; 1. Activation of Hb F synthesis -5-azacytidine 2. Antisickling agents acting on hemoglobin or membrane 3. Bone marrow transplantation